However, unlike hemophilia patients where a specific level of FVIII is associated with bleeding severity this is not true with Factor VII deficiency and replacement therapy is given on a clinical basis, which for the short half-life of Factor VII may need to be frequent. The gene discussed is F7; the disease is hyperinsulinemic hypoglycemia, familial, 4.